- Home
- MOLN vs STG Comparison
MOLN vs STG Comparison
Compare MOLN & STG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MOLN
- STG
- Stock Information
- Founded
- MOLN 2004
- STG 2003
- Country
- MOLN Switzerland
- STG China
- Employees
- MOLN N/A
- STG N/A
- Industry
- MOLN
- STG Other Consumer Services
- Sector
- MOLN
- STG Real Estate
- Exchange
- MOLN Nasdaq
- STG Nasdaq
- Market Cap
- MOLN 142.6M
- STG 118.9M
- IPO Year
- MOLN 2021
- STG 2018
- Fundamental
- Price
- MOLN $3.72
- STG $8.82
- Analyst Decision
- MOLN Hold
- STG
- Analyst Count
- MOLN 1
- STG 0
- Target Price
- MOLN $4.00
- STG N/A
- AVG Volume (30 Days)
- MOLN 5.2K
- STG 8.6K
- Earning Date
- MOLN 11-05-2025
- STG 08-14-2025
- Dividend Yield
- MOLN N/A
- STG N/A
- EPS Growth
- MOLN N/A
- STG N/A
- EPS
- MOLN N/A
- STG 3.59
- Revenue
- MOLN $856,302.00
- STG $279,374,215.00
- Revenue This Year
- MOLN N/A
- STG N/A
- Revenue Next Year
- MOLN $1,000.00
- STG N/A
- P/E Ratio
- MOLN N/A
- STG $2.45
- Revenue Growth
- MOLN N/A
- STG N/A
- 52 Week Low
- MOLN $3.36
- STG $4.28
- 52 Week High
- MOLN $7.60
- STG $15.00
- Technical
- Relative Strength Index (RSI)
- MOLN 50.93
- STG 46.35
- Support Level
- MOLN $3.69
- STG $8.11
- Resistance Level
- MOLN $3.85
- STG $8.95
- Average True Range (ATR)
- MOLN 0.21
- STG 0.56
- MACD
- MOLN 0.01
- STG -0.10
- Stochastic Oscillator
- MOLN 14.29
- STG 39.42
About MOLN Molecular Partners AG
Molecular Partners AG is a clinical stage biopharmaceutical company. The Company has programs in various stages of pre-clinical and clinical development, with oncology as its main focus. The firm develops protein therapeutics called DARPin therapeutics for the treatment of serious diseases, including cancer and sight-threatening disorders. The company's product pipeline is organized principally through three areas: Ophthalmology, including the creation of therapies for retinal diseases like wet age-related macular degeneration and diabetic macular edema; the Oncology pipeline comprises DARPin candidates with novel modes of action, including multi-DARPin compounds; and Immuno-oncology for anticancer treatment.
About STG Sunlands Technology Group
Sunlands Technology Group is a provider of online post-secondary and professional education services in China. The company offers various degree- and diploma-oriented post-secondary courses through its online platforms. In addition, it provides online professional courses and educational content to help students prepare for professional certification exams and attain professional skills. The Group has one operating segment, which is the provision of online education services.